These findings collectively highlight the dual role of CAT as both a protective antioxidant and modulator of treatment responses, emphasizing the need for the careful consideration of redox dynamics when integrating CAT-targeted strategies into lung cancer therapy. This evidence concerns the gene CAT and lung carcinoma.